Early Adverse Events and Immune Response Following Second and Third COVID-19 Vaccination in Pregnancy

Early Adverse Events and Immune Response Following Second and Third COVID-19 Vaccination in Pregnancy

(1) Background: The adverse-effect profile and short-term obstetric and neonatal outcomes among pregnant women who were vaccinated with the BNT162b2 vaccine at any stage of pregnancy do not indicate any safety concerns. The vaccine is effective in generating a humoral immune response in pregnant wom...

Full description

Bibliographic Details
Main Authors: Shlomi Toussia-Cohen, Yoav Yinon, Ravit Peretz-Machluf, Omri Segal, Noam Regev, Keren Asraf, Ram Doolman, Yonatan Kubani, Tal Gonen, Gili Regev-Yochay, Shiran Bookstein Peretz
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Journal of Clinical Medicine
Subjects:
adverse effects
BNT162b2 vaccine
COVID-19
pregnancy
SARS-CoV-2 IgG serum levels
third (booster) dose
Online Access:https://www.mdpi.com/2077-0383/11/16/4720

Internet

https://www.mdpi.com/2077-0383/11/16/4720

Similar Items